Cedars Sinai

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Lung cancer1 trial
• Ovarian cancer1 trial

Phase

• Phase 21 trial

Status

• Active, not recruiting2 trials

Lead sponsor

• Daiichi Sankyo1 trial
• M.D. Anderson Cancer Center1 trial

Running trials

• Active, not recruiting

  HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer

  NCT04619004· Phase 2· Daiichi Sankyo· Source

• Active, not recruiting

  Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer

  NCT02043158· M.D. Anderson Cancer Center· Source